| Tissue Specificity | Ubiquitously expressed. |
| Post Translational Modifications | Not glycosylated. Acetylated by histone acetyltransferase p300, deacetylated by HDACs. Acetylation/deacetylation states regulate transcriptional activity. Acetylation appears to activate transcription. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity. Ceramides can also regulate acetylation/deacetylation events through altering the interaction of HDAC with SP3. In vitro, C(18)-ceramides, but not C(16)-ceramides, increase the interaction of HDAC1 with SP3 and enhance the deacetylation of SP3 and the subsequent repression of the TERT promoter. Sumoylated on all isoforms. Sumoylated on 2 sites in longer isoforms with Lys-551 being the major site. Sumoylation at this site promotes nuclear localization to the nuclear periphery, nuclear dots and PML nuclear bodies. Sumoylation on Lys-551 represses the transactivation activity, except for the largest isoform, L-Sp3, which has little effect on transactivation. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity. |
| Function | Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping. |
| Protein Name | Transcription Factor Sp3Spr-2 |
| Database Links | Reactome: R-HSA-3232118 |
| Cellular Localisation | NucleusPml BodyLocalizes To The Nuclear Periphery And In Nuclear Dots When SumoylatedSome Localization In Pml Nuclear Bodies |
| Alternative Antibody Names | Anti-Transcription Factor Sp3 antibodyAnti-Spr-2 antibodyAnti-SP3 antibody |
Information sourced from Uniprot.org
